SCHEMBL8105152

SCHEMBL8105152

CC(C)c1ncnn1Cc1ccc(Cc2cccc(C(=O)O)c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.43
HDAC6 Q9UBN7 2/20 0.43
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA9 Q16790 1/20 0.43
MRGPRX4 Q96LA9 1/20 0.43
HTT P42858 1/20 0.43
IDO1 P14902 2/20 0.41
TDO2 P48775 1/20 0.41
YTHDC1 Q96MU7 1/20 0.39
PLA2G2A P14555 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HIF1A Q16665 1/20 0.39
FOLH1 Q04609 1/20 0.39
MEP1B Q16820 2/20 0.39
HCAR3 P49019 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8103500 0.86 PPARG (0.46) HDAC1HDAC6MRGPRX4NPC1RAB9A
SCHEMBL8095728 0.81 TSHR (0.49) HDAC1HDAC6CA1CA2CA9
SCHEMBL8110981 0.74 CA1 (0.40) POLBTDP1L3MBTL1CA1CA2
SCHEMBL8103529 0.73 AGTR1 (0.44) POLBTDP1L3MBTL1CA1CA2
SCHEMBL8096048 0.72 IDO1 (0.41) POLBTDP1L3MBTL1CA1CA2
SCHEMBL8103506 0.71 CA1 (0.39) POLBTDP1L3MBTL1CA1CA2
SCHEMBL1296450 0.71 CA1 (0.63) CA1CA2CA9PLA2G2ACYP2D6
SCHEMBL1926951 0.71 FOLH1 (0.66) CA1CA2CA9PLA2G2ACYP2D6
SCHEMBL70351 0.71 FOLH1 (0.70) CA1CA2CA9PLA2G2ACYP2D6
SCHEMBL30791058 0.71 FOLH1 (0.70) CA1CA2CA9PLA2G2ACYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3098772-B2 2000-10-16 JP claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP claimed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO claimed
EP-0527851-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1993-02-24 EP disclosed
US-5098920-A Hypotensive agents and treatment of congestive heart failure G. D. SEARLE & CO. (US) 1992-03-24 US disclosed
WO-1991017148-A1 1H-SUBSTITUTED-1,2,4-TRIAZOLE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-11-14 WO disclosed